Ikko Health vs FORE Biotherapeutics
Ikko Health vs FORE Biotherapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Ikko Health is on 45/100 and FORE Biotherapeutics on 56/100.
Where each one leads
Ikko Health
- headcount growth: +12.7% against +8.2%
FORE Biotherapeutics
- our overall score: 56/100 against 45/100
- agent readiness: 37/100 against 21/100
- headcount: 56 against 15
- funding raised: $232M against $1.0M
- LinkedIn following: 4,584 against 67
At a glance
| Measure | Ikko Health | FORE Biotherapeutics |
|---|---|---|
| What it is | Transforming healthcare by turning scientific fiction into scientific facts. | Precision oncology company developing cancer therapies guided by proprietary functional genomics. |
| Category | Healthcare, HealthTech, MedTech, Biotech | Healthcare, Drug Development, Genomics, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2021 | 2011 |
| Headquarters | London, United Kingdom | Philadelphia, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Ikko Health | FORE Biotherapeutics |
|---|---|---|
| Employees | 15 | 56 |
| Headcount growthLast 12 months | +12.7% | +8.2% |
| Total funding | $1.0M | $232M |
| Latest round | Seed | Series D-2 Extension |
| Valuation | Not published | $75.0M |
| LinkedIn followers | 67 | 4,584 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Ikko Health | FORE Biotherapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 45/100 | 56/100 |
| Traction | 42/100 | 58/100 |
| Team | 50/100 | 70/100 |
| Search visibility | 25/100 | 38/100 |
| Quality | 48/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | Not published | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Ikko Health | FORE Biotherapeutics |
|---|---|---|
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
Ikko Health vs FORE Biotherapeutics: common questions
Which is better, Ikko Health or FORE Biotherapeutics?
On our 0-100 score FORE Biotherapeutics rates higher (56/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Ikko Health and FORE Biotherapeutics compare on the numbers?
Ikko Health leads on headcount growth (+12.7% against +8.2%). FORE Biotherapeutics leads on our overall score (56/100 against 45/100), agent readiness (37/100 against 21/100), headcount (56 against 15), funding raised ($232M against $1.0M), LinkedIn following (4,584 against 67).
Read the full Ikko Health review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other Ikko Health alternatives we track.